Biyografi
Dr. M. Sait SAĞER; 2002 yılında İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi’nde Tıp Eğitimini tamamlayarak Tıp Doktoru olmuştur. 2002-2006 yılları arasında Cerrahpaşa Tıp Fakültesi Nükleer Tıp Anabilim Dalı’nda Nükleer Tıp ihtisasını tamamlamıştır. 2007 yılında Ordu Devlet Hastanesinde 2008 de Gata Haydarpaşa Eğitim Hastanesinde ve 2009-2010 yıllarında İstanbul Eğitim ve Araştırma Hastanesinde çalışmıştır. 2010-2015 yılları arasında İstanbul Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu, Tıbbı Görüntüleme Teknikleri proğramında Yardımcı Doçent kadrosuna atanmış ve görevlendirme ile Cerrahpaşa Tıp Fakültesi Nükleer Tıp Anabilim Dalında çalışmıştır. 2014 yılında Nükleer Tıp Doçent’i olmuştur.
Dr.M. Sait SAĞER Cerrahpaşa Tıp Fakültesi Nükleer Tıp Anabilim Dalında görev yapmaktadır. Tiroid hastalıkları ve Tiroid kanseri tedavisi, PET Görüntülemesi, Lutesyum-Yitrium Tedavisi gibi Nükleer Onkoloji ile ilgilenmektedir. European Society of Nuclear Medicine (Avrupa Nükleer Tıp Derneği) üyesi olan Dr. Sait SAĞER 2012 yılında İtalya’da gerçekleştirilen Board sınavını başarıyla geçerek European Fellowship of Board in Nuclear Medicine (FEBNM) belgesini almıştır.
Eğitim Bilgileri
2002 - 2006
2002 - 2006Tıpta Uzmanlık
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Nükleer Tıp Anabilim Dalı, Türkiye
1996 - 2002
1996 - 2002Lisans
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Türkiye
Yaptığı Tezler
2006
2006Tıpta Uzmanlık
Comparison of Tc-99m Hynic-Toc and Hynic-Tate Octreotid Scintigraphy with FDG-PET and MIBI in Thyroid Cancers Have Local Recurrences or Distant Metastases
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Nükleer Tıp
Yabancı Diller
B2 Orta Üstü
B2 Orta Üstüİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
Nükleer Tıp
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2022 - Devam Ediyor
2022 - Devam EdiyorProf. Dr.
İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2015 - 2023
2015 - 2023Doç. Dr.
İstanbul Üniversitesi, Dahili Bilimler
2010 - 2014
2010 - 2014Yrd. Doç. Dr.
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri
Yönetilen Tezler
2022
2022Tıpta Uzmanlık
Düşük-Orta Riskli Papiller Tiroid Kanserlerinde Prognostik Faktörlerin İncelenmesi
Sağer M. S. (Danışman)
D.Bilgiç(Öğrenci)
2016
2016Tıpta Uzmanlık
Over Kanserinin Primer evrelemesinde ve nüks/metastaz Araştırmasında PET//BT'nin Yeri
SAĞER M. S.
R.AKYEL(Öğrenci)
2013
2013Tıpta Uzmanlık
DİFERANSİYE TİROİD KANSERLERİNİN YENİDEN EVRELEMESİNDE PET/BT GÖRÜNTÜLEMENİN ÖNEMİ VE Tg SEVİYESİ İLE İLİŞKİSİNİN DEĞERLENDİRİLMESİ
SAĞER M. S.
Z.Rana(Öğrenci)
Makaleler
2025
20251. The contribution of PET/MRI in benign/malignant nodule separation in thyroid incidentalomas detected in FDG PET/CT imaging.
Nazari A., Sager S., Schenke S., Beşli L., SAMANCI C., ÖZTÜRK T., et al.
Revista clinica espanola
, cilt.225, sa.7, ss.502333, 2025 (Scopus)
2024
20242. RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population
Bilgiç S., Meral R., Sağer M. S., Sönmezoğlu K.
BMC CANCER
, sa.24, ss.12885-12986, 2024 (SCI-Expanded, Scopus)
2024
20243. 68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma
Şahin K., Kibar A., Güneren C., Sağer M. S., Sönmezoğlu K.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, sa.1, ss.54-56, 2024 (ESCI, TRDizin)
2023
20234. Synchronous occurrence of medullary and papillary thyroid cancer and survival rates
Akgun E., SAĞER M. S., Beytur F., NAZARI A., ÖZTÜRK T., TEKSÖZ S., et al.
INDIAN JOURNAL OF CANCER
, cilt.60, sa.4, ss.556-561, 2023 (SCI-Expanded, Scopus)
2023
20235. Comparison of Tc-99m Mebrofenin Scintigraphy with Other Parameters in Prediction of Patient Status in Y-90 Patients
Kibar A., Asa S., Aghazada F., Yeyin N., Abuqbeitah M., Sahin K., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)
2023
20236. Section-Based Regional Recognition of FDG PET/CT Images with Machine Learning
Asa S., Kibar A., Biyiklioglu S. E., Bodur M. T., Sager S., SÖNMEZOĞLU K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)
2023
20237. Dramatic treatment response images of a metastatic lung adenocarcinoma case with Osimertinib treatment on 18F-FDG PET/CT
Ince B., Namazova A., Bodur M., Asa S., Uslu-Besli L., Sager S., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)
2023
20238. Incidental Findings on 18F-Fluorocholine PET for Parathyroid Imaging
Namazova A., Nazari A., Ince B., Sager S., SÖNMEZOĞLU K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)
2023
20239. Comparison of Whole-Body Ga-68 DOTA TATE Positron Emission Tomography and Magnetic Resonance Imaging in the Detection of Bone Metastasis of Neuroendocrine Tumor in Simultaneous 3T Positron Emission Tomography/Computed Tomography
ASA S., Kibar A., BESLI L. U., Eryürekli A. E., SAMANCI C., SAĞER M. S., et al.
Cerrahpaşa Medical Journal
, cilt.47, sa.1, ss.7-13, 2023 (TRDizin)
2023
202310. Incidental Papillary Microcarcinoma and Papillary Thyroid Carcinoma in Multinodular Goiter
Arican C. D., Ozturk T., Sager M. S., Sertbudak I., Teksoz S., Saricoban C., et al.
ANALYTICAL CELLULAR PATHOLOGY
, cilt.2023, 2023 (SCI-Expanded, Scopus)
2022
202211. Using Visual Recognition Based Machine Learning For The Prediction Of Survival In Patients With Colorectal Cancer With Liver Metastasis
Asa S., Kibar A., Ince B., Nazari A., Aghazada F., Beytur F., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202212. Does Previous 177Lu DOTATATE Treatment Effect 90Y Microsphere Treatment in Neuroendocrine Tumor Patients with Liver Metastasis
Aghazada F., Kibar A., Ince B., Uslu-Besli L., SAMANCI C., Bas A., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202213. The contribution of PET/MR in benign malignant nodule separation in thyroid incidentalomas detected in FDG PET/CT imaging
Nazari A., Sager S., Bilgic S., Toplutas K., Beytur F., Besli L. U., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202214. Relationship between SUVmax and ADC values of metastatic lymph nodes also ADC values of metastatic and reactive lymph nodes detected by Ga-68 PSMA PET/MR in prostate cancer patients
Aghazada F., Kibar A., Uslu-Besli L., Sager S., SAYMAN H. B., SÖNMEZOĞLU K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202215. Ga-68 PSMA PET/MRI Imaging In Detecting Local Residue Or Recurrence In Patients With Prostate Cancer
Ince B., Besli L. U., Bakir B., Eken S., Sager S., DEMİRDAĞ Ç., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202216. The Effect Of High-Dose Radioiodine Therapy On Lacrimal Gland Function In Patients With Differentiated Thyroid Cancer
Namazova A., Sahin K., Guneren C., Ince B., Aghazada F., Sager S., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202217. Comparison of PET and MRI sequences separately in the detection of bone metastases in patients with neuroendocrine tumor who underwent 3T Ga-68 DOTA TATE PET/MR
Kibar A., Asa S., Uslu-Besli L., Eryurekli A., SAMANCI C., Sager S., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)
2022
202218. Diagnostic Performance of Tc-99m-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study
Schenke S. A., Campenni A., TUNCEL M., Bottoni G., Sager S., Bogovic Crncic T., et al.
DIAGNOSTICS
, cilt.12, sa.6, 2022 (SCI-Expanded, Scopus)
2022
202219. Author's Reply: Re: Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease
SAYMAN H. B., GÜLŞEN F., Sager S., AKGÜN E., YEYİN N., BİLGİÇ S., et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
, cilt.33, sa.3, ss.342, 2022 (SCI-Expanded, Scopus)
2022
202220. F-18-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Appearance of Gastrointestinal Behcet's Disease
İnce B., Kibar A., Asa S., Uslu Beşli R. L., Sağer M. S., Eşkazan A. E., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, cilt.31, sa.1, ss.57-59, 2022 (ESCI, TRDizin)
2022
202221. Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging
Akyel R., Akgun E., Akovali B., Sahin O. E., Sager S., AÇIKGÖZ A. S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.37, ss.174-181, 2022 (ESCI, Scopus, TRDizin)
2021
202122. Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism
Ozturk B., Atahan E., Gencer A., Harbiyeli D. O., Karabul E., Mazican N., et al.
ANNALS OF NUCLEAR MEDICINE
, cilt.35, sa.10, ss.1117-1125, 2021 (SCI-Expanded, Scopus)
2021
202123. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT
Asa S., Sönmezoğlu K., Uslu-Besli L., Şahin O. E., Karayel E., Pehlivanoglu H., et al.
ANNALS OF NUCLEAR MEDICINE
, cilt.35, ss.900-915, 2021 (SCI-Expanded, Scopus)
2021
202124. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients
Sager G., Akgun E., Abuqbeitah M., Uslu L., ASA S., Akgun M. Y., et al.
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.206, 2021 (SCI-Expanded, Scopus)
2021
202125. A case of hepatic focal nodular hyperplasia mimicking hepatocellular carcinoma identified on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography
BİLGİÇ S., SAYMAN H. B., SAĞER M. S., SÖNMEZOĞLU K.
WORLD JOURNAL OF NUCLEAR MEDICINE
, cilt.20, sa.2, ss.192-194, 2021 (ESCI)
2021
202126. Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging.
Sağer M. S., Bilgiç S., Uslu L., Asa S., Sağer G., Sönmezoğlu K.
Molecular imaging and radionuclide therapy
, cilt.30, sa.1, ss.57-59, 2021 (Scopus, TRDizin)
2020
202027. Complete response after ceritinib treatment in non-small cell lung cancer in an elderly patient
Sengul Samanci N., Celik E., Akovali B., Sager S., Demirelli F. H.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.8, ss.2031-2033, 2020 (SCI-Expanded, Scopus)
2020
202028. The impact of different computational assumptions in(131)I dosimetry for hyperthyroidism therapy
Abuqbeitah M., Sager S., DEMİR M., YEYİN N., AKOVALI B., SÖNMEZOĞLU K.
MEDICAL PHYSICS
, cilt.47, sa.11, ss.5810-5816, 2020 (SCI-Expanded, Scopus)
2020
202029. The contribution of SPECT/CT in patients with radionuclide shuntography through shunt dysfunction
Akgun E., AKGÜN M. Y., SAğER M. S., KAFADAR A. M.
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.196, 2020 (SCI-Expanded, Scopus)
2020
202030. Lu-177-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule
SAğER M. S., AYGÜN A., KARAYEL E., Pehlivanoglu H., SÖNMEZOĞLU K.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
, cilt.48, sa.1, ss.79-80, 2020 (ESCI, Scopus)
2020
202031. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in Conventional Imaging
Uslu-Beşli L., Sonmezoglu K., Teksoz S., Akgun E., Karayel E., Pehlivanoglu H., et al.
KOREAN JOURNAL OF RADIOLOGY
, cilt.21, sa.2, ss.236-247, 2020 (SCI-Expanded, Scopus)
2019
201932. Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study
Uslu-Besli L., Bakir B., Asa S., Guner E., Demirdag C., Sahin O. E., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, cilt.28, sa.3, ss.104-111, 2019 (ESCI, Scopus, TRDizin)
2019
201933. Prognostic value of ADC measurements in predicting overall survival in patients undergoing Y-90 radioembolization for colorectal cancer liver metastases
Alis D., Durmaz E. S. M., GÜLŞEN F., BAŞ A., KABASAKAL L., Sager S., et al.
CLINICAL IMAGING
, cilt.57, ss.124-130, 2019 (SCI-Expanded, Scopus)
2019
201934. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma
Sager S., Akgun E., USLU-BESLI L., Asa S., Akovali B., SAHIN O., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.40, sa.5, ss.461-468, 2019 (SCI-Expanded, Scopus)
2019
201935. Diagnostic capabilities of mri versus18 F FDG PET-CT in postoperative patients with thyroglobulin positive, 131 I-negative local recurrent or metastatic thyroid cancer
Samanci C., Onal Y., Sager S., Asa S., Ustabasioglu F. E., Alis D., et al.
Current Medical Imaging
, cilt.15, sa.10, ss.956-964, 2019 (SCI-Expanded, Scopus)
2019
201936. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients
USLU-BESLI L., Sager S., Akgun E., Asa S., Sahin O. E., Demirdag C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.1, ss.301-310, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201837. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography
Sager S., Vatankulu B., Sahin O. E., Cinaral F., Uslu L., Baran A., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.14, sa.5, ss.989-993, 2018 (SCI-Expanded, Scopus)
2018
201838. Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients
SAGER S., HATIPOGLU E., GUNES B., ASA S., Uslu L., SÖNMEZOGLU K.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
, cilt.9, sa.6, ss.177-183, 2018 (SCI-Expanded, Scopus)
2017
201739. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation
Uslu-Besli L., Kabasakal L., Sager S., Cicik E., Asa S., Sonmezoglu K.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.38, sa.11, ss.964-970, 2017 (SCI-Expanded, Scopus)
2017
201740. Comparison of Therapy Response Between PERCIST and RECIST Criteria After Yttrium-90 Therapy in HCC Patients
Sager S., Akgun E., Uslu L., Asa S., Sahin O. E., Akovali B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.44, 2017 (SCI-Expanded, Scopus)
2017
201741. Comparison of F-18 Choline PET/CT with Tc-99m MIBI and USG for Detection of Parathyroid Adenomas in Patients with Elevated Parathyroid Hormone Levels: Preliminary Results
Uslu-Beli L., Sonmezoglu K., Akgun E. K., Teksoz S., Karayel E., Pehlivanoglu H., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, 2017 (SCI-Expanded, Scopus)
2016
201642. Do F-18-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
Vatankulu B., Isik G., Kocael P., Kuyumcu S., Ilvan S., Sager S., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.37, sa.12, ss.1273-1281, 2016 (SCI-Expanded, Scopus)
2016
201643. Incidental Detection of Follicular Thyroid Carcinoma in Ga-68-PSMA PET/CT Imaging
Sager S., Vatankulu B., Uslu L., Sonmezoglu K.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
, cilt.44, sa.3, ss.199-200, 2016 (ESCI, Scopus)
2016
201644. Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?
Gunes B. Y., Onsel C., Sonmezoglu I., Ozaras R., Halac M., Tabak F., et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
, cilt.85, sa.3, ss.381-385, 2016 (SCI-Expanded, Scopus)
2016
201645. What is the role of florine-18 fluorodeoxyglucose/positron emission tomography/computed tomography imaging in well-differentiated thyroid cancers with negative iodine-131 scan high thyroglobulin and normal anti-thyroglobulin levels
Doner R. K., Sager S., Gortan F. A., Topuz O. V., Akyel R., Vatankulu B., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.12, sa.2, ss.1010-1017, 2016 (SCI-Expanded, Scopus)
2016
201646. Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients
Vatankulu B., AKSOY S. Y., Sager S., Halac M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.43, sa.3, ss.580-581, 2016 (SCI-Expanded, Scopus)
2016
201647. Assessment of treatment response with FDG PET/CT on a primary neuroendocrine tumor of vagina.
Vatankulu B., EKMEKCIOGLU O., AKSOY S., Sağer S., Halaç M.
Revista espanola de medicina nuclear e imagen molecular
, cilt.35, ss.143-4, 2016 (SCI-Expanded, Scopus)
2016
201648. The role of FDG PET/CT in detection of distant metastasis in the initial staging of breast cancer
Aliyev A., Aksoy S. Y., Ozhan M., Ekmekcioglu O., Vatankulu B., Kocael P. Ç., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.2, ss.349-360, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201649. Assessment of yttrium-90 citrate radiosynovectomy treatment with bone scintigraphy in lipoma arborescens.
Vatankulu B., NEMETYAZAR J., DEMIR Y., Samancı C., Sager S.
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
, cilt.31, ss.81-2, 2016 (ESCI, Scopus)
2016
201650. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes
Vatankulu B., Aksoy S. Y., Asa S., SAğER M. S., SAYMAN H. B., Halac M., et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
, cilt.35, sa.1, ss.17-21, 2016 (SCI-Expanded, Scopus)
2015
201551. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group
Sager S., Vatankulu B., Erdogan E., Mut S., Teksoz S., Ozturk T., et al.
Endocrine
, cilt.50, sa.1, ss.138-145, 2015 (SCI-Expanded, Scopus)
2015
201552. Positron Emission Tomography/Computed Tomography Findings in Malignant Otitis Externa
Gorur G. D., Halac M., Sager S., Sonmezoglu K., Sayman H. B., Uslu I.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, cilt.24, ss.10-12, 2015 (ESCI, TRDizin)
2015
201553. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
YILMAZ S., ALIYEV A., EKMEKCIOGLU O., OZHAN M., Uslu L., VATANKULU B., et al.
Nuklearmedizin. Nuclear medicine
, cilt.54, ss.262-71, 2015 (SCI-Expanded, Scopus)
2014
201454. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
Asa S., AKSOY S. Y., Vatankulu B., Aliyev A., Uslu L., OZHAN M., et al.
ANNALS OF NUCLEAR MEDICINE
, cilt.28, sa.10, ss.970-979, 2014 (SCI-Expanded, Scopus)
2014
201455. The role of FDG-PET/CT in detecting unsuspected and unknown distant metastasis in the initial staging of NSCLC
Halac M., Ozhan M., Yilmaz Aksoy S., Vatankulu B., Aliyev A., Asa S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.44, sa.6, ss.1029-1040, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201456. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers
Sager S., Asa S., Yilmaz M., Uslu L., Vatankulu B., Halac M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.10, sa.4, ss.922-926, 2014 (SCI-Expanded, Scopus)
2014
201457. FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection: response to Lazzeri et al
YILMAZ S., Vatankulu B., EKMEKCIOGU O., Sager S., Halac M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.41, sa.9, ss.1813-1814, 2014 (SCI-Expanded, Scopus)
2014
201458. Regional ventilation/perfusion mismatch pattern in patient with Swyer James (MacLeod's) syndrome
Sager S., Asa S., Akyel R., Atahan E., Kanmaz B.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES
, cilt.19, sa.9, ss.904-906, 2014 (SCI-Expanded, Scopus)
2014
201459. Comparison of Tc-99m pertechnetate images with dual-phase Tc 99m MIBI and SPECT images in primary hyperparathyroidism.
Sager S., SHAFIPOUR H., ASA S., YıLMAZ S., TEKSÖZ S., ONSEL C.
Indian journal of endocrinology and metabolism
, cilt.18, ss.531-6, 2014 (Scopus)
2014
201460. A rare case of solitary subcutaneous scalp metastasis from follicular thyroid carcinoma revealed with positron emission tomography/computed tomography: A case report and review
Sager S., Yilmaz S., Doner R. K., Niyazoglu M., Halac M., Kanmaz B.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.10, sa.2, ss.431-433, 2014 (SCI-Expanded, Scopus)
2014
201461. FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection
Aksoy S. Y., Asa S., Ozhan M., Ocak M., Sager M. S., Erkan M. E., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.41, sa.3, ss.556-564, 2014 (SCI-Expanded, Scopus)
2014
201462. Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT
Uslu L., Asa S., Sager S., Halac M.
NUKLEARMEDIZIN-NUCLEAR MEDICINE
, cilt.53, sa.2, 2014 (SCI-Expanded, Scopus)
2014
201463. PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer
Tural D., Selcukbiricik F., Sager S., Akar E., Yildiz O., Serdengecti S.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.10, sa.1, ss.121-126, 2014 (SCI-Expanded, Scopus)
2013
201364. Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with F-18-FDG-PET and MIBI images
Sager S., Kabasakal L., Ocak M., Maecke H., Uslu L., Halac M., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.34, sa.12, ss.1190-1195, 2013 (SCI-Expanded, Scopus)
2013
201365. Imaging of multiple brown tumors both in FDG (F-18) and Ga-68 DOTA-TATE PET/CT studies
Asa S., Yilmaz S., Kaya R., Sager S., Halac M., Kabasakal L.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
, cilt.32, sa.6, ss.404-405, 2013 (SCI-Expanded, Scopus)
2013
201366. PET/CT imaging of HIV-negative Kaposi's sarcoma
Sager S., Engin B., Kutlubay Z., Asa S., Sager S. G., Gucluer B., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.182, sa.4, ss.745-746, 2013 (SCI-Expanded, Scopus)
2013
201367. Preoperative and Postoperative (18)FDG PET/CT and Bone Scintigraphy Images in a Patient With Parathyroid Adenoma
Uslu L., CALIŞKAN A., SAGER S., TEKSÖZ S., HALAC M.
CLINICAL NUCLEAR MEDICINE
, cilt.38, sa.6, ss.456-458, 2013 (SCI-Expanded, Scopus)
2013
201368. Comparison of Tc-99m-HYNIC-TOC and HYNIC-TATE Octreotide Scintigraphy With FDG PET and Tc-99m-MIBI in Local Recurrent or Distant Metastatic Thyroid Cancers
Sager S., Kabasakal L., Halac M., Maecke H., Uslu L., Onsel C., et al.
CLINICAL NUCLEAR MEDICINE
, cilt.38, sa.5, ss.321-325, 2013 (SCI-Expanded, Scopus)
2013
201369. Pretherapy and posttherapy F-18-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma
Asa S., Aliyev A., Yilmaz S., Erkan M. E., Sager S., Halac M.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
, cilt.32, sa.1, ss.62-63, 2013 (SCI-Expanded, Scopus)
2013
201370. Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with F-18-FDG PET/CT
Uslu L., SEN F., SAGER S., HALAC M.
NUKLEARMEDIZIN-NUCLEAR MEDICINE
, cilt.52, sa.5, 2013 (SCI-Expanded, Scopus)
2012
201271. The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions
Yilmaz S., Ocak M., Asa S., Aliyev A., Ozhan M., Halac M., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.39, sa.10, ss.1660-1661, 2012 (SCI-Expanded, Scopus)
2012
201272. Delayed Imaging of the Pelvis With Diluted and Filled Bladder A Simple and Efficient Method in FDG PET/CT Imaging of Bladder Carcinoma
Halac M., Aliyev A., Yilmaz S., Ozhan M., Kaya R., Sager S., et al.
CLINICAL NUCLEAR MEDICINE
, cilt.37, sa.8, ss.778-780, 2012 (SCI-Expanded, Scopus)
2012
201273. Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT
Ergul N., Guner S. I., SAğER M. S., Huq G. E., Ciftci H., Cermik T. F.
MEDICAL ONCOLOGY
, cilt.29, sa.2, ss.1105-1108, 2012 (SCI-Expanded, Scopus)
2012
201274. Inguinal Herniation of the Bladder Mimicking Malignancy in FDG PET/CT: Original Image
Erkan E., Yilmaz S., Kaya Z. R., Sager S., TAN Y. Z., Halac M., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.32, sa.3, ss.895-897, 2012 (SCI-Expanded, Scopus)
2012
201275. Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours
Yilmaz S., Demirci E., Ocak M., Aygun A., Halac M., Sager S., et al.
JOURNAL OF NUCLEAR MEDICINE
, cilt.53, 2012 (SCI-Expanded, Scopus)
2012
201276. Case with Non-Small Cell Cancer in the Left Lung Diagnosed Following Observation of Bilateral Diffuse Lung Uptake of Tc-99m-MDP on Bone Scintigraphy
SAĞER M. S.
Turkiye Klinikleri J Med Sci
, cilt.32, sa.2, ss.570-573, 2012 (Hakemli Dergi)
2012
201277. F-18 FDG PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy
SAĞER M. S.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.21, ss.32-34, 2012 (TRDizin)
2012
201278. A Case with Non-Small Cell Cancer in the Left Lung Diagnosed Following Observation of Bilateral Diffuse Lung Uptake of Tc-99m-MDP on Bone Scintigraphy
Sager S., Ergul N., Ciftci H., Onur S., Cermik T. F.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.32, sa.2, ss.570-573, 2012 (SCI-Expanded, Scopus)
2012
201279. Positron emission tomography/computed tomography imaging of brown tumors mimicking multiple skeletal metastases in patient with primary hyperparathyroidism
SAĞER M. S.
Indian J Endocr Metab , cilt.16, ss.850-2, 2012 (Hakemli Dergi)
2011
201180. RADIATION PROTECTION FOR ACCOMPANYING PERSON AND RADIATION WORKERS IN PET/CT
Demir M., Demir B., Sayman H. B., Sager S., Ahmed A. S., Uslu I.
RADIATION PROTECTION DOSIMETRY
, cilt.147, sa.4, ss.528-532, 2011 (SCI-Expanded, Scopus)
2011
201181. The usefulness of PET/CT scan and metabolic tumour volume measurement in staging and evaluate the response for chemoradiotherapy in the patients with squamous cell head and neck cancer
Ekmekcioglu O., Kocak E., Ozer E., Sager S., Halac M., Sonmezoglu K., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201182. The value of Tc-99m HYNIC-TATE SPECT/CT in patients with recurrent or metastatic Medullary Thyroid Carcinoma
Asa S., Ekmekcioglu O., Ocak M., Decristoforo C., Arslan E., Kabasakal L., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201183. 99m Tc-HYNIC-TATE in detection of well differantiated thyroid cancer with negative radioiodine uptake
Asa S., Ekmekcioglu O., Ocak M., Decristoforo C., Arslan E., Kabasakal L., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201184. Radioembolization Using YTTRIUM-90 Microspheres for Advanced Primary and Metastatic Liver Malignancies
Uslu L., Arslan E., Ozhan M., Nisli S., Sager S., Kabasakal L., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201185. The role of FDG-PET/CT in detecting unsuspected distant metastasis in the staging of non-small cell lung cancer
Ozhan M., Halac M., Aliyev A., Yilmaz S., Sager S., Ergul N., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201186. Comparison of the aggressiveness of papillary thyroid microcarcinomas (<= 10 mm) with papillary thyroid carcinomas larger than 11 mm and less than 20 mm in diameter
Caliskan F. A., Uslu R. L., Sager S., Onsel C., Sayman H. B., Kabasakal L., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201187. 99mTc-EDDA/HYNIC-TATE scintigraphy: Results of 1 year experience in Turkey
Asa S., Ekmekcioglu O., Ocak M., Decristoforo C., Kabasakal L., Sager S., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded, Scopus)
2011
201188. Cardiac Hydatid Cyst Mimicking Malignancy
Yilmaz S., Ozhan M., Sager S., Halac M., Sonmezoglu K., Uslu I.
CLINICAL NUCLEAR MEDICINE
, cilt.36, sa.7, ss.580-581, 2011 (SCI-Expanded, Scopus)
2011
201189. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma
SAğER M. S., Ergul N., Ciftci H., Cetin G., Guner S. I., Cermik T. F.
SKELETAL RADIOLOGY
, cilt.40, sa.7, ss.843-847, 2011 (SCI-Expanded, Scopus)
2011
201190. The value of FD PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma
SAĞER M. S.
SKELETAL RADIOLOGY , cilt.40, ss.843-847, 2011 (SCI-Expanded, Scopus)
2011
201191. Böbrek Sintigrafisinde Kullanılan Radyofarmasötikler
SAĞER M. S.
Turk Urol Sem , cilt.2, ss.88-90, 2011 (Hakemli Dergi)
2011
201192. Unilateral thalamic hypometabolism on FDG brain PET in patient with temporal lobe epilepsy
SAĞER M. S.
Indian J Nucl Med , cilt.26, sa.2, ss.94-95, 2011 (Hakemli Dergi)
2010
201093. Temporal relationship between gastroesophageal reflux and rate of gastric emptying in children
Sager S., Halac M., Selcuk N., Dogan I., Kabasakal L., Onsel C., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.31, sa.12, ss.1059-1062, 2010 (SCI-Expanded, Scopus)
2010
201094. Intravascular radiation therapy with a Re-188 liquid-filled balloon in patients with in-stent restenosis
Selcuk N. A., Onsel C., OZTURK S., Gurmen T., Gulbaran M., Sager S., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.31, sa.8, ss.746-752, 2010 (SCI-Expanded, Scopus)
2010
201095. False positive F-18-FDG-PET/CT findings in a patient with talc pleurodesis
SAğER M. S., Ergul N., Ciftci H., Cermik T. F.
HELLENIC JOURNAL OF NUCLEAR MEDICINE
, cilt.13, sa.2, ss.179-180, 2010 (SCI-Expanded, Scopus)
2010
201096. The potential value of FDG PET/CT in staging and detecting bone marrow involvement of multiple myeloma
SAğER M. S., Ergul N., Cetin G., Ciftci H., Cermik T.
JOURNAL OF NUCLEAR MEDICINE
, cilt.51, 2010 (SCI-Expanded, Scopus)
2010
201097. Anorectal fistula appeareance mimicking malign lesion in F18 FDG PET/CT in a patient with lung cancer
SAĞER M. S.
Turk J Nucl Med
, cilt.19, sa.1, ss.45-46, 2010 (Hakemli Dergi)
2010
201098. Tc 99m bone scan and fluorodeoxyglucose positron emission tomography in evaluation of disseminated langerhans cell histiocytosis.
SAĞER M. S.
Indian J Nucl Med , cilt.25, sa.4, ss.164-167, 2010 (Hakemli Dergi)
2010
201099. False positive (18)F-FDG-PET/CT findings in a patient with talc pleurodesis
SAĞER M. S.
Hell J Nucl Med , cilt.13, sa.2, ss.179-80, 2010 (SCI-Expanded)
2009
2009100. F-18-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris
Kaya E., Halac M., Sonmezoglu K., Sager S., Uslu I.
HELLENIC JOURNAL OF NUCLEAR MEDICINE
, cilt.12, sa.3, ss.285-286, 2009 (SCI-Expanded, Scopus)
2009
2009101. Radiation Protection for Accompaniment Person in PET/CT
Nisli S., Demir M., Demir B., Kanmaz B., Tugrul A., Yilmaz G., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.36, 2009 (SCI-Expanded, Scopus)
2008
2008102. FDG PET/CT findings in recurrent malignant schwannoma
Halac M., Cinaral F., Sait S., Yilmaz S., Kerim S., Sergulen D., et al.
CLINICAL NUCLEAR MEDICINE
, cilt.33, sa.3, ss.172-174, 2008 (SCI-Expanded, Scopus)
2007
2007103. Female breast surface radiation exposure during FDG PET/CT examinations
Halac M., YILMAZ M. H., Sonmezoglu K., SAGER S., OZER H., YASAR D., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.28, sa.12, ss.924-928, 2007 (SCI-Expanded, Scopus)
2007
2007104. Is early bladder activity in radionuclide cisternography indirect sign of spontaneous intracranial hypotension sequence of lumbar puncture?
Halac M., Albayram S., Ceyhan E., Ozer H., Dogan I., Sager S., et al.
CLINICAL NUCLEAR MEDICINE
, cilt.32, sa.11, ss.850-853, 2007 (SCI-Expanded, Scopus)
2007
2007105. PET/CT findings in a multicentric form of Castleman's disease
Halac M., Ergull N., Sager S., Demir A., Buyukpinarbasli N., Sonmezoglu K.
HELLENIC JOURNAL OF NUCLEAR MEDICINE
, cilt.10, sa.3, ss.172-174, 2007 (SCI-Expanded, Scopus)
2007
2007106. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT
Akcali C., Zincirkeser S., Erbagcy Z., Akcali A., Halac M., Durak G., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.35, sa.4, ss.547-553, 2007 (SCI-Expanded, Scopus)
2007
2007107. Fluoro-18 fluorodeoxyglucose positron emission tomography/computerized tomography scans in a patient with penile cancer for appropriate therapeutic strategy
Halac M., Zincirkeser S., Soenmezoglu K., Sager S., Durak H., Uslu I.
HELLENIC JOURNAL OF NUCLEAR MEDICINE
, cilt.10, sa.2, ss.113-115, 2007 (SCI-Expanded, Scopus)
2007
2007108. Standardized uptake values of normal organs on F-18-fluorodeoxyglucose positron emission tomography and computed tomography imaging
Zincirkeser S., Sahin E., Halac M., Sager S.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.35, sa.2, ss.231-236, 2007 (SCI-Expanded, Scopus)
2006
2006109. Comparison of in-111 octreotide scintigraphy with tc-99m hynic-toc/tate scintigraphy in the same patient group for diagnosis of somatostatin receptor expressing tumors
Sager S., Kabasakal L., Yimaz S., Ocak M., Sanli Y., Maecke H., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.33, 2006 (SCI-Expanded, Scopus)
2006
2006110. Investigation of parallax effect within ring of a whole body PET
Demir B., Demir M., SAğER M. S., Halac M., Ahmed A., Uslu I.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.33, 2006 (SCI-Expanded, Scopus)
2006
2006111. Somatostatin scintigraphy in patients with cushing's syndrome (preliminary data)
Sager S., Kabasakal L., Ocak M., Halac M., Nisli C., Maecke H., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.33, 2006 (SCI-Expanded, Scopus)
2005
2005112. Kemik mineral yoğunluğu ölçümlerinde personel dozlarının değerlendirilmesi.
Demir B., DEMİR M., Sager S., Halaç M., Sürücü M., Yaşar D., et al.
Türkiye Nükleer Tıp Dergisi , cilt.14, ss.118-122, 2005 (Hakemli Dergi)
2005
2005113. Clinical Value of TC-99M Hynic-Octreotide and TC-99M Hynic-Octreotate Scintigraphy in Patients with Somatostatin Expressing Tumours
Sager S., Kabasakal L., Ocak M., Nisli C., Maecke H., Onsel C., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005114. Value of the First Thyroglobulin Level and Uptake Percentage by the Remnant for the Diagnosis of Metastases after Thyroidectomy and Correlation with Post-Ablation Scanning
Sager S., Onsel C., Kabasakal L., Sonmezoglu K., Sayman H. B., Kanmaz B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005115. Intravascular Radiation Therapy (IVRT) With A Re-188-Liquid Filled Balloon In Patients With In-Stent Restenosis. This study is supported by the International Atomic Energy Agency (IAEA)
Kavlak E., Selcuk N., Onsel C., Sager S., Gurmen T., Tufekcioglu S., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005116. Radioguided Occult Lesion Localization (ROLL) of the Nonpalpable Suspicious Breast Lesions
Sager S., Halac M., Sayman H. B., Kabasakal L., Kanmaz B., Sonmezoglu K., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005117. Clinical Experience with TC-99m Hynic-Toc and Hynic-Tate Octreotid Scintigraphy in the Follow-Up of Thyroid Cancers
Sager S., Kabasakal L., Halac M., Kasikcioglu D., Ocak M., Maecke H., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005118. Comparison of TC-99m Hynic-Octreotide and TC-99m Hynic-Octreotate in the same Patient Group with Somatostatin Receptor Expressing Tumors
Kabasakal L., Sager S., Ocak M., Maecke H., Nisli C., Onsel C., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005119. The Value of Different Washout Parameters in the Evaluation of Renal Transplants by Using TC-99M-N,N-Ethylenedicysteine
Kanmaz B., Sayman H. B., Devranoglu G., Halac M., Kabasakal L., Onsel C., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.32, 2005 (SCI-Expanded, Scopus)
2005
2005120. Kemik mineral yoğunluğu ölçümlerinde personel dozlarının değerlendirmesi
DEMİR B., DEMİR M., SAĞER M. S., HALAÇ M., sürücü m., Yaşar D., et al.
turkish journal of nuclear medicine , cilt.14, ss.118-122, 2005 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Radiosynovectomy with Lu-177 MAA in Patients with Inflammatory Knee Joint: Preliminary Results
Saglam K., SAĞER M. S., Bilgic S., Karayel E., Pehlivanoglu H., Aygun A., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, (Özet Bildiri)
2023
20232. Evaluation of Liver Lesions with Diffusion Weighted Imaging PET/MRI in Transarterial Radioembolization Treatment Patients
Kibar A., Aghazada F., Uslu-Besli L., Sahin O. E., Asa S., Sager S., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Eylül 2023, (Özet Bildiri)
2021
20213. Evaluation of treatment efficiency in 301 patients with hyperthyroidism treated with a single dose of I-131 as outpatient
Ince B., Namazova A., Bilgiç S., Nazari A., Kibar A., Aghazada F., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vienna, Avusturya, 20 - 23 Ekim 2021, cilt.48, sa.1, ss.380, (Özet Bildiri)
2020
20204. F-18 DOPA PET imaging in hyperinsulinemic hypoglicemia
Toplutas K., Uslu-Besli L., Asa S., Sager S., Karayel E., Pehlivanoglu H., et al.
33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri)
2020
20205. Selective Intraarterial Lu-177 PSMA Therapy for Castration Resistant Prostate Cancer: Preliminary Results of a Pilot Study
Sayman H. B., Gulsen F., Sager S., Akgun E., Yeyin N., Bilgic S., et al.
33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri)
2019
20196. Comparison Of Ga-68 PSMA PET/MRI With Textural Analysis Data In Transitional Zone Prostate Tumors: Preliminary Results Of An On-Going Study
Uslu L. L., Tuncer S., Bakir B., Yildiz S. O., Demirdag C., Guner E., et al.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)
2019
20197. The Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up
Toplutas K., Sager S., Besli R. L., Asa S., Khosroshahi S., Sayman H. B., et al.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)
2019
20198. Value Of Hybrid F-18 FDG PET/MRI In BIRADS 4 And 5 Breast Lesions: Preliminary Results Of An On-Going Study
Uslu L. L., Yilmaz R., Velidedeoglu M., Sahin O. E., Akgun E., Sager S., et al.
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)
2018
20189. A new device (COTI) for thyroid uptake measurement and prospective dosimetry oriented therapy
Abuqbeitah M., DEMİR M., Yeyin N., Gray D., Sager S., Uslu-Besli L., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2018
201810. Comparison of Ga-68 PSMA PET/CT and Ga-68 PSMA PET/MRI with biparametric prostate MRI in terms of location and extension of primary prostate gland tumour
Besli L. U., Asa S., Bakir B., Sayman H. B., Sager S., Khosroshahi B. R., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2018
201811. Contribution of 68Ga-PSMA-11 PET/CT imaging in Gleason Score 3+3=6 Prostate Cancer
Sahin O. E., Gilgic S., Sager S., Akovali B., Akgun E., Uslu-Besli L., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, (Özet Bildiri)
2018
201812. Correlation of SUVmax and ADC values detected by Ga-68 PSMA PET/MRI in primary prostate lesions and their significance in lymph node metastasis
Uslu-Besli L., Asa S., Bakir B., Sayman H. B., Sager S., Khosroshahi B. R., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2018
201813. The feasibility of relying on dose calculation for more successive therapy in Graves and Toxic adenoma guided by one year follow up
Abuqbeitah M., Sager S., Yeyin N., Uslu-Besli L., DEMİR M., Sonmezoglu K.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, sa.1, (Özet Bildiri)
2018
201814. Is low-dose radioiodine treatment sufficient for a successful remnant tissue ablation in low-moderate risk thyroid cancer patients?
Khosroshahi S. R., Sahin O. E., Besli L. U., Sager S., Asa S., Akgun E., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2018
201815. Comparison of PET and DWI images in the detection of bone metastasis of prostate cancer in Ga-68 PSMA PET / MR
Asa S., Besli R. L., Ozgur E., Khosroshahi S., Bakir B., Demirdag C., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2018
201816. Du¨s¸u¨k Doz radyoaktif ı-131 Tedavisi Ablasyonda Beklentileri kars¸ılıyor mu?
RAZAVIKHOSROSHAHI S., ŞAHİN O. E., SAĞER M. S., ASA S., USLU BEŞLİ R. L., AKGÜN E., et al.
30. Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 12 - 14 Nisan 2018, ss.21, (Özet Bildiri)
2018
201817. THE ASSOCIATION OF ALKALINE PHOSPHATASE WITH BONE HEALTH PARAMETERS IN TURKISH POSTMENOPAUSAL WOMEN
Tuzun S., Akarirmak U., Sager S., Alcicek M. N., Sonmezoglu K., Enisa S., et al.
WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Krakow, Polonya, 19 - 22 Nisan 2018, cilt.29, (Özet Bildiri)
2016
201618. 68Ga-DOTA-TATE PET-CT in differentiated thyroid cancer patients: comparison with 18F-FDG PET-CT
Vatankulu B., Akovali B., Sager S., Halac M., Kabasakal L., Sonmezoglu K.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)
2016
201619. 68Ga-PSMA HBED-CC PET/CT imaging may be useful in detection of differentiated thyroid cancer: a comparative study with 68Ga-DOTA-TATE PET/CT and 18F-FDG PET/CT imaging
Vatankulu B., Akgun E., Ocak M., Demirci E., Uslu L., Sager S., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)
2016
201620. Comparison of first day and second day imaging in evaluating sentinel lymph node with SPECT/CT in breast cancer
Vatankulu B., Akgun E., Velidedeoglu M., Sager S., Halac M., Sonmezoglu K.
Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)
2016
201621. The Comparison Of F-18 FDG PET/BT VE Tc-99m MIBI SPECT/BT In Multiple Myeloma
Khosroshahi S. R., Sayman H., Berk S., Balkanay O., Nematyazar J., Vatankulu B., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)
2015
201522. Accuracy of 18F-FDG-PET/CT in staging, restaging, and treatment response in patients with male breast cancer
Vatankulu B., Kuyumcu S., Kocael P. Ç., Işık E., Asa S., Sager S., et al.
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri)
2015
201523. Comparison of Early and Late SUVmax Values of Somatostatin Reseptor Positive Lesions in Ga-68 DOTATATE PET/CT Images
Nematyazar J., Sager S., Sahin O. E., Razavi B., Akyel R., Vatankulu B., et al.
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri)
2015
201524. Predictive value of early dynamic and static FDG PET / CT findings in evaluation of primary lung lesions
Vatankulu B., Bakan S., Şahin O. A., Sager S., Halac M., Sayman H. B., et al.
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri)
2015
201525. Correlation Between Day 3 and Day 5 Blood Test Results After Thyrotropin Alfa (Thyrogen) Injection In Differentiated Thyroid Cancer Patients
Sager S., Nisli C., Sahin O. E., Akyel R., Rezavi B., Nemetyazar J., et al.
28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, (Özet Bildiri)
2014
201426. Is there any role of dual phase FDG-PET/CT scan in restaging of differentiated thyroid cancer?
Khosroshahi S. B. R., Nematyazar J., Vatankulu B., Sager S., Halac M., Sayman H. B., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri)
2014
201427. The Role and Importance of FDG PET/CT in Assessment of Malignancy Focus in Paraneoplastic Neurologic Syndrome
Vatankulu B., ASA S., Sager S., Sayman H. B., Sonmezoglu K., Halac M., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri)
2013
201328. Is Adding Hounsfield Unit Measurement on Standardized Uptake Value Helpful in Differentiating Thyroid Nodules?
Sayman H. B., Uslu L., Topuz O. V., Sager S., Halac M., Sonmezoglu K.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)
2013
201329. Dual time point imaging with F-18 FDG-PET/CT in Spondylodiscitis
Gunes B. Y., Onsel C., Sager S., Halac M., Sonmezoglu K., Tabak F., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)
2013
201330. Comparison of SPECT/CT, Gamma Probe and Methylene Blue-Dye For Sentinel Lymph Node Detection in Gynecologic Tumours
Asa S., Sager S., Demirayak G., Nemetyazar J., Halac M., Onsel C., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)
2013
201331. The value of thyroglobulin measurement in fine needle aspirates from cervical lymph nodes of thyroid cancer patients
Sayman H. B., Yilmaz S., Nisli S., Ozhan M., Uslu L., Akyel R., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Lyon, Fransa, 19 - 23 Ekim 2013, cilt.40, (Özet Bildiri)
2012
201232. Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours
YILMAZ S., DEMİRCİ E., OCAK DEMİRCİ E. M., AYGÜN A., Halac M., SAğER M. S., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)
2012
201233. Radioembolization with Yttrium-90 Microspheres in Unresectable Primary and Metastatic Liver Tumors
Uslu L., Gulsen F., Sager S., Pekmezci S., Cantasdemir M., Kabasakal L., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)
2012
201234. Comparison of I-123 MIBG Scintigraphy with Ga-68 Octreotide PET/CT Imaging in Neuroblastoma Patients
Uslu L., Sager S., Kabasakal L., Tuysuz G., Celkan T., Apak H., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)
2012
201235. The role of FDG PET/CT in initial staging of patients with newly diagnosed breast cancer with an emphasis on distant metastasis
Aliyev A., Halac M., Yilmaz S., Erkan M., Asa S., Ozhan M., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)
2012
201236. Comparison of Y-90 PET and Bremsstrahlung SPECT images after Radioembolization with Y-90 Microspheres
Uslu L., Sager S., Halac M., Kabasakal L., Uslu I., Demir M., et al.
25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)
2011
201137. Multipl Brown tümörlü bir olguda iskelet sisteminde yaygın metastaz görünümü veren PET/BT bulguları
SAĞER M. S.
4. PET-BT Sempozyumu, Konya, Konya, Türkiye, 09 Kasım 2011 - 13 Kasım 2001, ss.58, (Tam Metin Bildiri)
2010
201038. Radiation Protection for Accompanying Person and Radiation Workers in PET/CT
DEMİR M., DEMİR B., SAYMAN H. B., SAğER M. S., Ahmed A., Uslu I.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri)
2009
200939. Tüberküloz nedeni ile takip edilen şüpheli kaviter lezyonda PET-BT ile akciğer kanseri tanısı
SAĞER M. S.
PET-BT Sempozyumu, Erzincan, Türkiye, 5 - 08 Şubat 2009, ss.61, (Tam Metin Bildiri)
2007
200740. Comparison of TC-99m hynic-Toc and Hynic-Tate octreotid scintigraphy with FDG-PET and MIBI in thyroid cancers have local recurrences or distant metastases
SAğER M. S., Kabasakal L., Halac M., Ergul N., Kanmaz B., SÖNMEZOĞLU K., et al.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri)
2007
200741. Evaluation of focal thyroid uptakes detected by FDG-PET/CT scanning
Cinaral F., Halac M., Sager S., Yilmaz S., Erdogan E., Ergul N., et al.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri)
2007
200742. The diagnostic role of FDG-PET in fever of unknown origin
Ergul N., Halac M., Sager S., Yilmaz S., Cinaral F., Erdogan E., et al.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri)
2007
200743. Impact of injection dose and scan duration on PET images within the lung region for overweight-patients: A phantom study
Demir M., Demir B., Sager S., Halac M., Sabbir A., Uslu I.
20th Annual Congress of the European-Association-of-Nuclear-Medicine, Copenhagen, Danimarka, 01 Ocak 2007, cilt.34, (Özet Bildiri)
2005
200544. Clinical Value of Tc-99m Hynic Octreotide and Tc-99m Hynic Octreotide Scintigraphy in Patients with Somatostatin Expressing Tumors
SAĞER M. S.
Annual Congress of the EANM, Istanbul, Eur J Nucl Med, İstanbul, Türkiye, 16 - 20 Ekim 2005, cilt.32, ss.108-109, (Özet Bildiri)
2005
200545. Radioguided occult lesion localization (ROLL) of the nonpalpable suspicious breast lesions
SAĞER M. S.
Annual Congress of the EANM, Istanbul,, İstanbul, Türkiye, 16 - 20 Ekim 2005, cilt.32, ss.136, (Tam Metin Bildiri)
2005
200546. Value of the first Thyroglobulin level and uptake percentage by the remnant for the diagnosis of metastases after thyroidectomy and correlation with post-ablation scanning
SAĞER M. S.
Annual Congress of the EANM, Istanbul, İstanbul, Türkiye, 16 - 20 Ekim 2005, cilt.32, ss.241, (Tam Metin Bildiri)
2005
200547. Somatostatin Reseptörü Bulunan Tümörlerde Tc-99m Hynic-Octreotide ve Tc-99m Hynic-Octreotate Sintigrafisi
SAĞER M. S.
Nükleer Tıp Sempozyomu Pozitron Emisyon Tomografisi, Ankara, Türkiye, 12 - 14 Ocak 2005, ss.14, (Özet Bildiri)
2004
200448. Clinical experience with Tc-99m Hynic/TOC and Tc-99m Hynic/TATE in somatostatin receptor positive lesions: Preliminary report
Kabasakal L., Sager S., Nisli C., Maecke H., Onsel C., Uslu I.
Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri)
2004
200449. I-131 uptake augmentation by thiazide diuretics in differentiated thyroid cancer patients
Sayman H. B., Senmevsim O., Kanmaz B., Mete C., Sager S., Onsel C., et al.
17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri)
2004
200450. Evaluation of the temporal distribution of reflux episodes and the relationship of gastric emptying rate in the gastroesophageal reflux scintigraphy
Sager S., Halac M., Selcuk N., Dogan I., Kabasakal L., Onsel C., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri)
Kitaplar
2018
20181. Percutaneous Ethanol Injection (PEI) in a Patient with Cystic Thyroid Nodule
SAĞER M. S.
Thyroid and Parathyroid Diseases, Özülker T, Adaş M, Günay S. , Editör, Springer-Verlag , London, ss.476, 2018
2010
20102. Gastrointestinal Sistemde Nükleer Tıp
SAĞER M. S.
Nükleer Tıp Ders Kitabı, "Önsel Ç.", Editör, İstanbul Üniversitesi, İstanbul, ss.176-185, 2010
Desteklenen Projeler
2019 - 2021
2019 - 2021Tiroid Nodüllerinin Bening/Malign Ayırımında FDG PET/MR'ın Yeri
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
SAĞER M. S. (Yürütücü), USLU BEŞLİ R. L., BİLGİÇ S., RAZAVİKHOSROSHAHİ S., GÜLŞEN F., ASA S.
2017 - 2018
2017 - 2018Comparison of F18 Choline PETCT with Tc99m MIBI and USG for Detection of Parathyroid Adenomas in Patients with Elevated Parathyroid Hormone Levels Preliminary Results
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
USLU BEŞLİ R. L. (Yürütücü), AKGÜN E., PEHLİVANOĞLU H., KARAYEL E., ÖZTÜRK T., SAĞER M. S.
2015 - 2015
2015 - 2015
Correlation Between Day 3 and Day 5 Blood Test Results After Thyrotropin Alfa (Thyrogen) Injection In Differentiated Thyroid Cancer Patients
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAĞER M. S. (Yürütücü)
2012 - 2015
2012 - 2015MIBI Paratiroid Sintigrafisinde SPECT ve Pinhole imajlarının Karşılaştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAĞER M. S. (Yürütücü)
2013 - 2013
2013 - 2013Comparison of SPECT/CT, Gamma Probe and Methylene Blue-Dye For Sentinel Lymph Node Detection in Gynecologic Tumours
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAĞER M. S. (Yürütücü)
2011 - 2012
2011 - 2012Gasroözefagial Reflü Görülen Hastalarda Tedavi Sonrası Değerlendirme
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAĞER M. S. (Yürütücü)
Patent
2021
2021RADYOAKTİF LUTESYUM-177 İLE BÜYÜK PARTİKÜL ÇAPLI ALBUMİN (MAKRO-AGGREGATED ALBUMİN) İŞARETLENMESİ
Patent
Başvuru Yapıldı, Buluşun Başvuru Numarası: 2018/01074 , Standart Tescil
2018
2018METASTATİK KARACİĞER TÜMÖRLERİNİN TEDAVİSİNDE LUTESYUM 177-MAA MOLEKÜLLERİNİN KULLANIMI
Patent
Başvuru Yapıldı, Buluşun Başvuru Numarası: 2018-01074 , Standart Tescil
Bilimsel Kuruluşlardaki Üyelikler / Görevler
2004 - Devam Ediyor
2004 - Devam EdiyorAvrupa Nükleer Tıp Derneği
Üye
2003 - Devam Ediyor
2003 - Devam EdiyorTürkiye Nükleer Tıp Derneği
Üye
Kongre ve Sempozyum Katılımı Faaliyetleri
01 Nisan 2014 - 01 Nisan 2014
01 Nisan 2014 - 01 Nisan 201426. Ulusal Nükleer Tıp Kongresi
Katılımcı
Antalya-Türkiye
01 Ekim 2013 - 01 Ekim 2013
01 Ekim 2013 - 01 Ekim 2013